http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 18 Jun 2026 18:35:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26667541.html si-local-file:///var/storage/secattach/20260618/26667541.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26667541.html Thu, 18 Jun 2026 18:35:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26667541.html si-local-file:///var/storage/secattach/20260618/26667541.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26667541.html Thu, 18 Jun 2026 18:35:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Wheeler+Cameron/26666699.html si-local-file:///var/storage/secattach/20260618/26666699.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Wheeler+Cameron/26666699.html Thu, 18 Jun 2026 16:36:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Wheeler+Cameron/26666699.html si-local-file:///var/storage/secattach/20260618/26666699.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Wheeler+Cameron/26666699.html Thu, 18 Jun 2026 16:36:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Squarer+Ron/26666682.html si-local-file:///var/storage/secattach/20260618/26666682.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Squarer+Ron/26666682.html Thu, 18 Jun 2026 16:35:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Squarer+Ron/26666682.html si-local-file:///var/storage/secattach/20260618/26666682.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Squarer+Ron/26666682.html Thu, 18 Jun 2026 16:35:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Srivastava+Sapna/26666690.html si-local-file:///var/storage/secattach/20260618/26666690.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Srivastava+Sapna/26666690.html Thu, 18 Jun 2026 16:35:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Srivastava+Sapna/26666690.html si-local-file:///var/storage/secattach/20260618/26666690.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Srivastava+Sapna/26666690.html Thu, 18 Jun 2026 16:35:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Protopapas+Anna/26666676.html si-local-file:///var/storage/secattach/20260618/26666676.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Protopapas+Anna/26666676.html Thu, 18 Jun 2026 16:34:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Protopapas+Anna/26666676.html si-local-file:///var/storage/secattach/20260618/26666676.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Protopapas+Anna/26666676.html Thu, 18 Jun 2026 16:34:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Meyers+Michael+L./26666656.html si-local-file:///var/storage/secattach/20260618/26666656.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Meyers+Michael+L./26666656.html Thu, 18 Jun 2026 16:33:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Meyers+Michael+L./26666656.html si-local-file:///var/storage/secattach/20260618/26666656.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Meyers+Michael+L./26666656.html Thu, 18 Jun 2026 16:33:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Oliger+Christy+J./26666663.html si-local-file:///var/storage/secattach/20260618/26666663.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Oliger+Christy+J./26666663.html Thu, 18 Jun 2026 16:33:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Oliger+Christy+J./26666663.html si-local-file:///var/storage/secattach/20260618/26666663.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Oliger+Christy+J./26666663.html Thu, 18 Jun 2026 16:33:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Bogle+Grant+C./26666639.html si-local-file:///var/storage/secattach/20260618/26666639.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Bogle+Grant+C./26666639.html Thu, 18 Jun 2026 16:32:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Bogle+Grant+C./26666639.html si-local-file:///var/storage/secattach/20260618/26666639.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+Bogle+Grant+C./26666639.html Thu, 18 Jun 2026 16:32:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16/26666602.html si-local-file:///var/storage/secattach/20260618/26666602.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16/26666602.html Thu, 18 Jun 2026 16:31:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16/26666602.html si-local-file:///var/storage/secattach/20260618/26666602.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16/26666602.html Thu, 18 Jun 2026 16:31:00 -0400 NUVL O.51068808 http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651768.html <p>MONSEY, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl &amp; Fruchter LLP is investigating the fairness of the proposed sale of Nuvalent, Inc. (Nasdaq: NUVL) (“NUVL”) for $124.00 per share in cash to GSK in a tender offer.</p> <p>The sale price is well below the price targets of multiple Wall Street analysts before the deal was announced, including:</p> <ul type="disc"><li style="margin-top:5pt; margin-bottom:5pt;">Colleen Kusy of Robert W. Baird ($158.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Bradley Canino of Guggenheim ($151.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Gregory Renza of Truist Financial ($140.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">David Dai of UBS http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651768.html Tue, 16 Jun 2026 09:20:00 -0400 NUVL http://www.streetinsider.com/Globe+Newswire/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651768.html <p>MONSEY, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl &amp; Fruchter LLP is investigating the fairness of the proposed sale of Nuvalent, Inc. (Nasdaq: NUVL) (“NUVL”) for $124.00 per share in cash to GSK in a tender offer.</p> <p>The sale price is well below the price targets of multiple Wall Street analysts before the deal was announced, including:</p> <ul type="disc"><li style="margin-top:5pt; margin-bottom:5pt;">Colleen Kusy of Robert W. Baird ($158.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Bradley Canino of Guggenheim ($151.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Gregory Renza of Truist Financial ($140.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">David Dai of UBS http://www.streetinsider.com/Globe+Newswire/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651768.html Tue, 16 Jun 2026 09:20:00 -0400 NUVL http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26amp%3B+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651771.html <p>MONSEY, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl &amp; Fruchter LLP is investigating the fairness of the proposed sale of Nuvalent, Inc. (Nasdaq: NUVL) (“NUVL”) for $124.00 per share in cash to GSK in a tender offer.</p> <p>The sale price is well below the price targets of multiple Wall Street analysts before the deal was announced, including:</p> <ul type="disc"><li style="margin-top:5pt; margin-bottom:5pt;">Colleen Kusy of Robert W. Baird ($158.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Bradley Canino of Guggenheim ($151.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Gregory Renza of Truist Financial ($140.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">David Dai of UBS http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26amp%3B+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651771.html Tue, 16 Jun 2026 09:20:00 -0400 A.09621214 A.21446405 NUVL O.00003925 O.51068808 O.51342647 http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26amp%3B+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651771.html <p>MONSEY, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl &amp; Fruchter LLP is investigating the fairness of the proposed sale of Nuvalent, Inc. (Nasdaq: NUVL) (“NUVL”) for $124.00 per share in cash to GSK in a tender offer.</p> <p>The sale price is well below the price targets of multiple Wall Street analysts before the deal was announced, including:</p> <ul type="disc"><li style="margin-top:5pt; margin-bottom:5pt;">Colleen Kusy of Robert W. Baird ($158.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Bradley Canino of Guggenheim ($151.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Gregory Renza of Truist Financial ($140.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">David Dai of UBS http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26amp%3B+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651771.html Tue, 16 Jun 2026 09:20:00 -0400 A.09621214 A.21446405 NUVL O.00003925 O.51068808 O.51342647 http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26amp%3B+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651771.html <p>MONSEY, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl &amp; Fruchter LLP is investigating the fairness of the proposed sale of Nuvalent, Inc. (Nasdaq: NUVL) (“NUVL”) for $124.00 per share in cash to GSK in a tender offer.</p> <p>The sale price is well below the price targets of multiple Wall Street analysts before the deal was announced, including:</p> <ul type="disc"><li style="margin-top:5pt; margin-bottom:5pt;">Colleen Kusy of Robert W. Baird ($158.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Bradley Canino of Guggenheim ($151.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Gregory Renza of Truist Financial ($140.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">David Dai of UBS http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26amp%3B+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651771.html Tue, 16 Jun 2026 09:20:00 -0400 A.09621214 A.21446405 NUVL O.00003925 O.51068808 O.51342647 http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26amp%3B+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651771.html <p>MONSEY, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl &amp; Fruchter LLP is investigating the fairness of the proposed sale of Nuvalent, Inc. (Nasdaq: NUVL) (“NUVL”) for $124.00 per share in cash to GSK in a tender offer.</p> <p>The sale price is well below the price targets of multiple Wall Street analysts before the deal was announced, including:</p> <ul type="disc"><li style="margin-top:5pt; margin-bottom:5pt;">Colleen Kusy of Robert W. Baird ($158.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Bradley Canino of Guggenheim ($151.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Gregory Renza of Truist Financial ($140.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">David Dai of UBS http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26amp%3B+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651771.html Tue, 16 Jun 2026 09:20:00 -0400 A.09621214 A.21446405 NUVL O.00003925 O.51068808 O.51342647 http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26amp%3B+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651771.html <p>MONSEY, N.Y., June 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl &amp; Fruchter LLP is investigating the fairness of the proposed sale of Nuvalent, Inc. (Nasdaq: NUVL) (“NUVL”) for $124.00 per share in cash to GSK in a tender offer.</p> <p>The sale price is well below the price targets of multiple Wall Street analysts before the deal was announced, including:</p> <ul type="disc"><li style="margin-top:5pt; margin-bottom:5pt;">Colleen Kusy of Robert W. Baird ($158.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Bradley Canino of Guggenheim ($151.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">Gregory Renza of Truist Financial ($140.00 price target)</li><li style="margin-top:5pt; margin-bottom:5pt;">David Dai of UBS http://www.streetinsider.com/Press+Releases/NUVL+Alert%3A+Monsey+Firm+of+Wohl+%26amp%3B+Fruchter+Investigating+Fairness+of+the+Proposed+Sale+of+Nuvalent+to+GSK/26651771.html Tue, 16 Jun 2026 09:20:00 -0400 A.09621214 A.21446405 NUVL O.00003925 O.51068808 O.51342647